Company intelligence / Profile preview

Causaly

London, England, United Kingdomcausaly.com ↗

Ownership: Private
Employees: ~118
Development stage: Other

Overview

Causaly provides an advanced generative AI and knowledge graph platform that accelerates biomedical research, drug discovery, biomarker identification, and disease understanding by automating the extraction of insights from vast scientific literature. The platform is used by major pharmaceutical companies and regulatory agencies to reduce R&D timelines and improve decision-making in life sciences. There are no clinical results as it is not developing drugs.

Industry: Drug Discovery Services

Partnerships

GileadNovo NordiskRegeneronFDANational Institute of Environmental Health Sciences

Beyond the preview

Go deeper on Causaly.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Causaly.

Explore the full profile